Medicine and Dentistry
Fecal Microbiota Transplantation
100%
Infection
71%
Clostridium Difficile Infection
35%
Prospective Cohort Study
28%
Vancomycin
19%
Antibiotics
17%
Cohort Analysis
16%
Patient with Inflammatory Bowel Disease
16%
Hemicolectomy
14%
Colon Cancer
14%
Bile Acid Malabsorption
14%
Thiamine
14%
Drug Megadose
14%
Maintenance Therapy
14%
Loose Feces
14%
Small Intestinal Bacterial Overgrowth
14%
Fidaxomicin
14%
Ustekinumab
14%
Placebo
14%
Inflammatory Bowel Disease
14%
Metabolite
14%
Clinical Management
14%
Feces
9%
Colonoscopy
6%
Adverse Event
6%
Fibroblast Growth Factor 19
6%
Odds Ratio
5%
Riboflavin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
72%
Feces microflora
71%
Inflammatory Bowel Disease
31%
Cohort Study
30%
Ustekinumab
28%
Clostridium Difficile Infection
21%
Vancomycin
16%
Antibiotic Agent
15%
Nonalcoholic Fatty Liver
14%
Vedolizumab
14%
Prospective Cohort Study
14%
Fidaxomicin
14%
Thiamine
14%
Riboflavin
5%
Keyphrases
Fecal Microbiota Transplantation
28%
Scoping Review
14%
Fidaxomicin
14%
Method Validation
14%
Real-world Effectiveness
14%
Clostridium Difficile Infection
14%
Clinical Resolution
8%